Botox offers hope to women with incontinence

January 29, 2013

When most people hear Botox, they think of injections to the face to combat wrinkles and aging.

While its first use may have been cosmetic, doctors have since begun using the muscle weakening protein to treat patients with neurological disorders, migraines and, now, female incontinence.

is FDA approved for patients who have urge incontinence caused by an overactive or neurogenic bladder. This common type of incontinence causes bladder spasms and results in urinary leakage.

According to Vanessa Elliott, a at Penn State Hershey Medical Center, the procedure takes only a few minutes, requires numbing, not sedation, and is pain-free. It eliminates a patient's need for daily medication and the unwanted side effects of those drugs.

Essentially, the procedure goes like this: Doctors place a scope inside the patient's bladder, a small needle goes through the scope, and the Botox is injected into the wall of the bladder.

Botox is not the first line of treatment, Elliott says. The drug is costly and often has to be approved by , with some requiring proof that other medications were tried and failed.

Patients are first offered daily medication in the form of a pill, patch or gel to treat the problem. For the vast majority of women, the drugs either fail to work or cause intolerable side effects such as , constipation, , and, in older patients, confusion. The side effects force patients to discontinue use even if the medication worked for the bladder.

Once they have tried and failed one or two of those medicines, patients are then offered Botox, Elliott says. They generally need to repeat the procedure every six to 12 months and have no systemic side effects, as the Botox only affects the bladder.

The injections allow incontinence patients to go to the bathroom less frequently and have fewer incidents of leakage between bathroom visits. For some patients, who have or and have to catheterize themselves every 4 to 6 hours during the day, the Botox procedure allows them to stay dry in between catheterizations.

"The improvement is significant if Botox works for these patients," said Elliott, who reports a 75-percent success rate with the procedure.

The procedure does have risks. Because the needle is stuck into the bladder multiple times, a small risk of blood in the urine exists. There's also a small risk of getting a urinary tract infection. Patients receive antibiotics to combat this possibility, and Elliot said she will not do the procedure on anyone with an active infection.

Elliot said that the biggest risk is if a provider uses the full FDA-approved dose. A possibility exists for the bladder to become so relaxed that the patient can't void on her own temporarily. Only about 10 percent of women experience this after the procedure and need to catheterize themselves for a few weeks to a couple months until the effect diminishes.

Explore further: FDA gives nod to botox to treat overactive bladder

Related Stories

FDA gives nod to botox to treat overactive bladder

January 19, 2013
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval for the use of Botox against a form of urinary incontinence known as overactive bladder.

US approves Botox for bladder control

August 24, 2011
The face-freezing pharmaceutical injection Botox gained another medical use on Wednesday when the US government approved it for use in some patients with overactive bladder.

Botox now used for urinary incontinence

March 14, 2012
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the U.S. Food and Drug Administration (FDA) approved using the injections to help patients ...

Study shows benefits, drawbacks, for women's incontinence treatments

October 4, 2012
Oral medication for treating a type of incontinence in women is roughly as effective as Botox injections to the bladder, reported researchers who conducted a National Institutes of Health clinical trials network study, with ...

Bladder 'pacemaker' can fix overactive bladder, other voiding issues

April 29, 2011
If your day is punctuated by urgent trips to the bathroom or trouble emptying your bladder, you might have a voiding dysfunction condition. The good news is that it can be easily treated.

Recommended for you

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.